The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, March 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 20 X posts from 18 X users, with an upper bound of 43,714 followers.

RT @TSpiresJones: Very proud to have participated in this paper in @AlzheimersRes with @CogRx and the synaptic endpoints working group argu…

RT @CogRx: This morning we announced the publication of an article in @AlzheimersRes (https://t.co/myZ6fHZ3mp) in which the Synaptic Health…

This morning we announced the publication of an article in @AlzheimersRes (https://t.co/myZ6fHZ3mp) in which the Synaptic Health Endpoints Working Group reviews available and experimental #biomarkers for #neurological diseases such as #Alzheimers: https://

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease https://t.co/3ZfoZmuqNm https://t.co/Wtx8xoqkGl

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 16 additional X posts.